Overall rank by patents
#29,495
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Molecular Loop Biosciences, Inc.
USPTO PatentsView assignee record - 9 granted patents across 2 technology areas, active 2021–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).
9
Total patents granted
2
CPC technology areas
12.4
Avg claims per patent
-
5-year filing velocity
The verdict
Molecular holds 9 US patents across 2 technology areas, rank #29,495 of 50,000 tracked assignees.
- #29,495
- of 50,000 US assignees by volume
- Top 36%
- by Innovation Score (40.4/100)
- 12.4
- avg claims per patent
Portfolio overview
Molecular Loop Biosciences, Inc. has been granted 9 US utility patents between 2021 and 2024, placing Molecular Loop Biosciences, Inc. at rank #29,495 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.4 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a US Corporation, Molecular Loop Biosciences, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Molecular sits between Modular Services Comopany (9 patents, rank #29,491) and Motion Control, Inc. (9 patents, rank #29,499) - the closest US assignees by grant volume. The composite Innovation Score of 40.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2024, with 9 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Molecular Loop Biosciences, Inc.'s 12.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Molecular Loop Biosciences, Inc. against peers pursuing similar technology classes.
Who files at Molecular's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Modular Services…
Modular Services Comopany
9 patents
- Modulate
Modulate, Inc.
9 patents
- Mogas Industries
Mogas Industries, Inc.
9 patents
- Molmed Spa
MolMed SpA
9 patents
- Mologen
Mologen AG
9 patents
- Molon Labe
Molon Labe LLC
9 patents
- Monumo
Monumo Limited
9 patents
- Motion Control
Motion Control, Inc.
9 patents
- Molecular Loop Bi… ◀
Molecular Loop Biosciences, Inc.
9 patents
What this shows Molecular holds 9 patents at rank #29,495, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Molecular
By rank, the assignees closest to #29,495 in granted patent volume.
Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)
Other assignees with the most granted patents in Molecular's primary technology class.
- The Regents Of The University Of California 581 in class
- Life Technologies Corporation 546 in class
- Illumina, Inc. 445 in class
- President And Fellows Of Harvard College 387 in class
- Immatics Biotechnologies Gmbh 286 in class
- 10x Genomics, Inc. 282 in class
- The Board Of Trustees Of The Leland Stanford Junior University 266 in class
- Pacific Biosciences OF California, Inc. 259 in class
Molecular's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
40 Top 36% higher than 64% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 2 | 22.2% |
| 2022 | 2 | 22.2% |
| 2023 | 3 | 33.3% |
| 2024 | 2 | 22.2% |
Which technologies does Molecular Loop Biosciences, Inc. patent most?
Top 2 of 2 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Standard
Frequently Asked Questions
How many patents does Molecular Loop Biosciences, Inc. hold?
Molecular Loop Biosciences, Inc. holds 9 US granted patents filed between 2021 and 2024, spanning 2 technology areas.
What is Molecular Loop Biosciences, Inc.'s Innovation Score?
Molecular Loop Biosciences, Inc. has an Innovation Score of 40.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Molecular Loop Biosciences, Inc. focus on?
Molecular Loop Biosciences, Inc.'s top technology area is C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES) with 9 patents. The company has filed patents in 2 CPC subclasses total.
Is Molecular Loop Biosciences, Inc.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Molecular Loop Biosciences, Inc..
What does claim depth mean for Molecular Loop Biosciences, Inc.'s patents?
Molecular Loop Biosciences, Inc.'s patents average 12.4 claims each. This falls within the standard range, providing solid legal coverage.
How is the Molecular Loop Biosciences, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Molecular's 9 grants land it in the top 36% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Molecular ranks #29,495 of 50,000. Top 50 holders
- Most of this portfolio concentrates in C12Q - see who else leads that technology area. C12Q leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.